Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men

被引:20
|
作者
Kopp, Tine Iskov [1 ,2 ]
Friis, Soren [2 ]
Christensen, Jane [2 ]
Tjonneland, Anne [2 ]
Vogel, Ulla [3 ]
机构
[1] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark
[2] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[3] Natl Res Ctr Working Environm, Copenhagen, Denmark
关键词
Prostate cancer; genetic epidemiology; inflammation; gene-gene interaction; gene-environment interaction; polymorphism; COX-2; IL-1; beta; NF-kappa B; PPAR-gamma; nested case-control study; ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BODY-MASS INDEX; CYCLOOXYGENASE-2; GENE; DIABETES-MELLITUS; BREAST-CANCER; EXPRESSION; ASSOCIATION; INTERLEUKIN-1;
D O I
10.1016/j.cancergen.2013.06.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The etiology of prostate cancer (PC) remains mostly unknown, but increasing evidence suggests that chronic inflammation in the prostate is associated with an increased risk of PC. Epidemiological studies have suggested that use of nonsteroidal anti-inflammatory drugs (NSAIDs) may protect against PC. Inborn variations in genes involved in the inflammatory response may modulate the risk of PC and interact with NSAIDs. The aims of this study were 1) to evaluate whether polymorphisms and haplotypes of the inflammation-related genes COX-2, II1B, NFKB1, and PPARG are associated with risk of PC; 2) to investigate gene-environment interactions between polymorphisms and NSAID use; and 3) to examine whether the studied polymorphisms were associated with the aggressiveness of PC. The study population consisted of 370 cases of PC and 370 risk-set matched (age) controls nested within the prospective Danish "Diet, Cancer, and Health" cohort. Carriers of the variant deletion allele of NFKB1 -94ins/delATTG had a tendency toward a reduced risk of PC (incidence rate ratio (IRR), 0.73; 95% confidence interval (Cl) 0.52-1.04). A lowered risk for PC was also found for carriers of variant allele NFKB1-94ins/delATTG among non-users of NSAIDs (IRR 0.68; 95% Cl 0.47-0.99), for non-aggressive disease (IRR 0.64; 95% Cl 0.42-0.99), and among men with a body mass index above 30 kg/m(2) (IRR 0.56; 95% Cl 0.27-1.16), although the latter estimate was based on small numbers. A similar pattern was seen for the variant C allele of the COX-2 +8473T -> C polymorphism. No apparent association with PC was observed for the other studied polymorphisms. Our study did not indicate that chronic inflammation is a major risk factor for aggressive PC.
引用
收藏
页码:266 / 278
页数:13
相关论文
共 50 条
  • [31] Polymorphisms of DNA repair genes are risk factors for prostate cancer
    Hirata, Hiroshi
    Hinoda, Yuji
    Tanaka, Yuichiro
    Okayama, Naoko
    Suehiro, Yutaka
    Kawamoto, Ken
    Kikuno, Nobuyuki
    Majid, Shahana
    Vejdani, Kaveh
    Dahiya, Rajuir
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 231 - 237
  • [32] Polymorphisms in oxidative stress pathway genes and prostate cancer risk
    Zhenzhen Zhang
    Duo Jiang
    Chi Wang
    Mark Garzotto
    Ryan Kopp
    Beth Wilmot
    Philippe Thuillier
    Andy Dang
    Amy Palma
    Paige E. Farris
    Jackilen Shannon
    Cancer Causes & Control, 2019, 30 : 1365 - 1375
  • [33] Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk
    Jianjun Zhang
    Ishwori B. Dhakal
    Nicholas P. Lang
    Fred F. Kadlubar
    Cancer Causes & Control, 2010, 21 : 1437 - 1444
  • [34] Polymorphisms in oxidative stress pathway genes and prostate cancer risk
    Zhang, Zhenzhen
    Jiang, Duo
    Wang, Chi
    Garzotto, Mark
    Kopp, Ryan
    Wilmot, Beth
    Thuillier, Philippe
    Dang, Andy
    Palma, Amy
    Farris, Paige E.
    Shannon, Jackilen
    CANCER CAUSES & CONTROL, 2019, 30 (12) : 1365 - 1375
  • [35] Risk perception and risk comprehension among men with prostate cancer
    Kendel, Friederike
    Feufel, Markus
    ONKOLOGE, 2019, 25 (04): : 352 - 357
  • [36] Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer
    Eriksen, A. K.
    Kyro, C.
    Norskov, N.
    Bolvig, A. K.
    Christensen, J.
    Tjonneland, A.
    Overvad, K.
    Landberg, R.
    Olsen, A.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (10) : 1235 - 1240
  • [37] Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer
    A K Eriksen
    C Kyrø
    N Nørskov
    A K Bolvig
    J Christensen
    A Tjønneland
    K Overvad
    R Landberg
    A Olsen
    European Journal of Clinical Nutrition, 2017, 71 : 1235 - 1240
  • [38] Insomnia among elderly men and risk of prostate cancer
    Sigurdardottir, Lara
    Valdimarsdottir, Unnur Anna
    Mucci, Lorelei
    Fall, Katja
    Rider, Jennifer R.
    Schernhammer, Eva S.
    Czeisler, Charles A.
    Launer, Lenore
    Harris, Tamara B.
    Stampfer, Meir J.
    Gudnason, Vilmundur
    Lockley, Steven W.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [39] Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial
    Tang, Li
    Platek, Mary E.
    Yao, Song
    Till, Cathee
    Goodman, Phyllis J.
    Tangen, Catherine M.
    Wu, Yue
    Platz, Elizabeth A.
    Neuhouser, Marian L.
    Stanczyk, Frank Z.
    Reichardt, Juergen K. V.
    Santella, Regina M.
    Hsing, Ann
    Figg, William D.
    Lippman, Scott M.
    Thompson, Ian M.
    Ambrosone, Christine B.
    CARCINOGENESIS, 2018, 39 (02) : 125 - 133
  • [40] STATIN USE AND RISK OF PROSTATE CANCER IN A POPULATION OF MEN SCREENED FOR PROSTATE CANCER
    Tan, Nelly
    Klein, Eric
    Li, Jianbo
    Moussa, Ayman
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2011, 185 (04): : E186 - E187